These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16610922)

  • 1. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
    Marshall DA; Strauss ME; Pericak D; Buitendyk M; Codding C; Torrance GW
    Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a scheduled narcotic for chronic pain with a similar medication for breakthrough pain only is not a clinically relevant comparison.
    Basskin L
    Am J Manag Care; 2006 Jul; 12(7):412; author reply 412-5. PubMed ID: 16834528
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
    Choi CB; Song JS; Kang YM; Suh CH; Lee J; Choe JY; Lee CK; Shim SC; Chung WT; Song GG; Kim HA; Ji JD; Nam EJ; Park SH; Hong YH; Sheen DH; Lim MK; Seo YI; Sung YK; Kim TH; Lee JT; Bae SC
    Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
    Hass B; Lungershausen J; Hertel N; Poulsen Nautrup B; Kotowa W; Liedgens H
    Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis.
    Kamath CC; Kremers HM; Vanness DJ; O'Fallon WM; Cabanela RL; Gabriel SE
    Value Health; 2003; 6(2):144-57. PubMed ID: 12641865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: results of a randomized controlled clinical trial.
    Bulthuis Y; Mohammad S; Braakman-Jansen LM; Drossaers-Bakker KW; van de Laar MA
    Arthritis Rheum; 2008 Feb; 59(2):247-54. PubMed ID: 18240191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of clinical interventions for AIDS wasting.
    Beaston-Blaakman A; Shepard DS; Stone N; Shevitz AH
    AIDS Care; 2007 Sep; 19(8):996-1001. PubMed ID: 17851996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study.
    Xie F; Lo NN; Tarride JE; O'Reilly D; Goeree R; Lee HP
    Eur J Health Econ; 2010 Feb; 11(1):27-34. PubMed ID: 19430952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumferential fusion is dominant over posterolateral fusion in a long-term perspective: cost-utility evaluation of a randomized controlled trial in severe, chronic low back pain.
    Soegaard R; Bünger CE; Christiansen T; Høy K; Eiskjaer SP; Christensen FB
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2405-14. PubMed ID: 18090078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oxycodone/acetaminophen and codeine/acetaminophen vs. conventional therapy in elderly women with persistent, moderate to severe osteoarthritis-related pain.
    Corsinovi L; Martinelli E; Fonte G; Astengo M; Sona A; Gatti A; Massaia M; Bo M; Zanocchi M; Michelis G; Isaia G; Molaschi M
    Arch Gerontol Geriatr; 2009; 49(3):378-82. PubMed ID: 19150139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
    Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.